ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,305, issued on Aug. 4, was assigned to CORNELL UNIVERSITY (Ithaca, N.Y.).

"Nucleoside analogs and use thereof in therapeutic treatment" was invented by Ethel Cesarman (Jersey City, N.J.), Utthara Nayar (Boston), J. David Warren (New York) and Jouliana Sadek (Roosevelt Island, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to novel nucleoside analog compounds and methods for treating diseases characterized by high expression levels of adenosine kinase (ADK)."

The patent was filed on Nov. 30, 2023, under Application No. 18/525,031.

*For further information, including images, charts and tables, please visit: htt...